Outcome

This study highlights the potential benefits of hyperbaric oxygen therapy (HBOT) in managing blood sugar levels and improving insulin sensitivity in type 2 diabetes patients who have experienced an intracerebral hemorrhage. The findings reveal that HBOT significantly increased the glucose infusion rate by 37.8%±5.76% at one month after the onset of therapy alongside reductions in serum insulin fasting glucose and hemoglobin A1C levels.

Introduction

Introduction:

This study explores the promising effects of hyperbaric oxygen therapy (HBOT) on enhancing peripheral insulin sensitivity in type 2 diabetes patients who have suffered an intracerebral hemorrhage. With 52 participants divided into two groups based on stroke onset the researchers administered a series of HBOT sessions and monitored changes in glucose infusion rate fasting glucose serum insulin and hemoglobin A1C levels. The results were encouraging: HBOT improved insulin sensitivity significantly with a 37.8% increase in glucose infusion rate one month after onset along with notable reductions in fasting glucose and hemoglobin A1C levels. Additionally early and late outcomes measured by the National Institutes of Health Stroke Scale (NIHSS) showed substantial improvement in HBOT-treated patients compared to the control group. This study indicates HBOT as a potentially effective and safe adjunctive treatment for diabetes patients with acute stroke offering valuable insights into better blood sugar management and stroke recovery.

Results

The study investigated the effects of hyperbaric oxygen therapy (HBOT) on peripheral insulin sensitivity in type 2 diabetes patients who suffered an intracerebral hemorrhage. A total of 52 participants were divided into two groups based on the timing of stroke onset: within 10 days and within 30 days.

Key findings demonstrated a significant increase in glucose infusion rate by 37.8% one month post-HBOT intervention. Additionally there were marked reductions in serum insulin fasting glucose and hemoglobin A1C levels. Both early (approximately 10 days post-onset) and late (one month post-onset) NIHSS scores showed substantial improvements in the HBOT group compared to baseline values with the differences being statistically significant (P<0.001 for both early and late outcomes). Conversely the control group exhibited significant improvements only in the late NIHSS scores (P<0.05).

Furthermore the study observed statistically significant differences between the HBOT and control groups when comparing both early and late NIHSS outcomes indicating a more pronounced impact of HBOT on recovery (P<0.05).

In summary HBOT effectively increased peripheral insulin sensitivity and improved clinical outcomes in type 2 diabetes patients following an acute stroke. The therapy emerged as a potentially safe and beneficial adjunctive treatment for managing diabetes in patients who experience intracerebral hemorrhage.

Conclusion

In conclusion this study demonstrates the significant benefits of hyperbaric oxygen therapy (HBOT) in enhancing peripheral insulin sensitivity and improving clinical outcomes in type 2 diabetes patients who have suffered an intracerebral hemorrhage. The key findings highlight a substantial increase in glucose infusion rate by 37.8% one month post-HBOT coupled with reductions in serum insulin fasting glucose and hemoglobin A1C levels. Notably NIHSS score improvements were significantly more pronounced in the HBOT group compared to baseline and the control group indicating accelerated and enhanced recovery.

These results signify that HBOT could serve as a valuable adjunctive treatment for managing blood sugar levels and insulin sensitivity in diabetic patients following an acute stroke. The therapy not only aids in stroke recovery but also offers a promising approach to better blood sugar management in diabetes. Future research should explore the long-term effects of HBOT on glycemic control and stroke rehabilitation potentially broadening its application and optimizing treatment protocols for this patient population.